Senior VP, R&D of REPLIGEN CORP (NASDAQ:RGEN), Kuriyel Ralf, sells 6,802 shares worth $1,286,870
According to REPLIGEN CORP's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 14 06:48 PM, company Senior VP, R&D, Kuriyel Ralf disclosed selling 6,802 shares at a cost of $189.19. At the time of this transaction (Jun 10), this trade was worth $1,286,870 in total. As of Jun 10, Kuriyel Ralf now owns 21,355 shares in total worth about $4,145,859.6999999997.
For the last few recent trades made by REPLIGEN CORP (NASDAQ:RGEN) Senior VP, R&D, Kuriyel Ralf, we have the following information:
- SEC Form 4 filing: May 14: Sold 710 shares at the rate of $172.29 per share. Total worth of this trade was $122,326. Total number of shares owned as of May 14 were 24,555
- SEC Form 4 filing: Mar 10: Sold 8,000 shares at the rate of $190.44 per share. Total worth of this trade was $1,523,501. Total number of shares owned as of Mar 10 were 25,265
- SEC Form 4 filing: Mar 04: Sold 2,075 shares at the rate of $192.00 per share. Total worth of this trade was $398,396. Total number of shares owned as of Mar 04 were 25,265
Posted by
George Daniels
on Tuesday June 15 2021, 11:04 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
